(Q45029914)

8 December 2017

title

Relapse in patients with schizophrenia: a comparison between risperidone and haloperidol (English)

1 reference

8 December 2017

0 references

1 reference

Eduardo Pondé de Sena

1

1 reference

8 December 2017

Rogério Santos-Jesus

2

1 reference

8 December 2017

Angela Miranda-Scippa

3

1 reference

8 December 2017

Lucas de Castro Quarantini

4

1 reference

8 December 2017

Irismar Reis de Oliveira

5

1 reference

8 December 2017

publication date

1 October 2003

1 reference

Brazilian Journal of Psychiatry

8 December 2017

published in

1 reference

8 December 2017

volume

25

1 reference

8 December 2017

issue

4

1 reference

8 December 2017

page(s)

220-223

1 reference

Cost of relapse in schizophrenia

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462003000400007

Overview: maintenance therapy in psychiatry: I. Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462003000400007

Fluphenazine and social therapy in the aftercare of schizophrenic patients. Relapse analyses of a two-year controlled study of fluphenazine decanoate and fluphenazine hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462003000400007

Symptoms, signs, and diagnosis of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462003000400007

Neuroleptics and the Natural Course of Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462003000400007

Pharmacologic treatment of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462003000400007

Factors influencing relapse in the long-term course of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462003000400007

Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462003000400007

Risperidone in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462003000400007

Risperidone versus haloperidol: I. Meta-analysis of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462003000400007

The evaluation and treatment of first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462003000400007

A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462003000400007

Risperidone versus haloperidol in long-term hospitalized chronic patients in a double blind randomized trial: a post hoc analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462003000400007

Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462003000400007

Rehospitalization rates of chronically ill schizophrenic patients discharged on a regimen of risperidone, olanzapine, or conventional antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462003000400007

Risperidone in the treatment of schizophrenia: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462003000400007

Relapse and Rehospitalization During Maintenance Treatment of Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462003000400007

10.1590/S1516-44462003000400007

21 January 2018

Identifiers

DOI

1 reference

8 December 2017

1 reference